1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Drug Delivery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Drug Delivery Market Regional Analysis
6.2 North America Drug Delivery Market Revenue 2021-2028 (US$ Million)
6.3 North America Drug Delivery Market Forecast Analysis
7. North America Drug Delivery Market Analysis – by Route of Administration
7.1 Injectable Drug Delivery
- 7.1.1 Overview
- 7.1.2 Injectable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Oral Drug Delivery
- 7.2.1 Overview
- 7.2.2 Oral Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Transmucosal Drug Delivery
- 7.3.1 Overview
- 7.3.2 Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Topical Drug Delivery
- 7.4.1 Overview
- 7.4.2 Topical Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 Implantable Drug Delivery
- 7.5.1 Overview
- 7.5.2 Implantable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Ocular Drug Delivery
- 7.6.1 Overview
- 7.6.2 Ocular Drug Delivery: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. North America Drug Delivery Market Analysis – by Distribution Channel
8.1 Hospital Pharmacies
- 8.1.1 Overview
- 8.1.2 Hospital Pharmacies: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Retail Pharmacies
- 8.2.1 Overview
- 8.2.2 Retail Pharmacies: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Online Pharmacies
- 8.3.1 Overview
- 8.3.2 Online Pharmacies: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. North America Drug Delivery Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Home Care Settings
- 9.2.1 Overview
- 9.2.2 Home Care Settings: North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Other End Users
- 9.3.1 Overview
- 9.3.2 Other End Users : North America Drug Delivery Market – Revenue and Forecast, 2021-2028 (US$ Million)
10. North America Drug Delivery Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Drug Delivery Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.2.1.1 North America Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.1.2 US: North America Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.1.3 US: North America Drug Delivery Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.2.2 Canada: North America Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.2.3 Canada: North America Drug Delivery Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Drug Delivery Market Breakdown, by Route of Administration
- 10.2.1.3.2 Mexico : North America Drug Delivery Market Breakdown, by Distribution Channel
- 10.2.1.3.3 Mexico : North America Drug Delivery Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bausch Health Companies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Baxter International Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Becton Dickinson and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boehringer Ingelheim International GmbH
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Boston Scientific Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Gerresheimer AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 GlaxoSmithKline Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Johnson & Johnson
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Kindeva Drug Delivery LP
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novartis AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Novo Nordisk AS
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Pfizer Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Sever Pharma Solutions
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations